
Conformis CFMS
Quarterly report 2023-Q2
added 08-02-2023
Conformis Cash and Cash Equivalents 2011-2026 | CFMS
Annual Cash and Cash Equivalents Conformis
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 48.7 M | 101 M | 28.7 M | 26.4 M | 16.4 M | 18.3 M | 37.3 M | 117 M | 37.9 M | 54.2 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 M | 16.4 M | 48.6 M |
Quarterly Cash and Cash Equivalents Conformis
| 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.2 M | 37.8 M | 48.7 M | 59.6 M | 73.1 M | 83.3 M | 101 M | 97.7 M | 109 M | 105 M | 29.1 M | 28.7 M | 28.7 M | 28.7 M | 26.4 M | 26.4 M | 26.4 M | 26.4 M | 16.4 M | 16.4 M | 16.4 M | 16.4 M | 18.3 M | 18.3 M | 18.3 M | 18.3 M | 37.3 M | 37.3 M | 37.3 M | 37.3 M | 117 M | 117 M | 117 M | 117 M | 37.9 M | 37.9 M | 37.9 M | - | 54.2 M | - | - | - | 39.7 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 117 M | 16.4 M | 49.4 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | ||
|
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
161 M | $ 10.23 | -0.97 % | $ 1.54 B | ||
|
EDAP TMS S.A.
EDAP
|
24.7 M | $ 3.45 | 3.29 % | $ 129 M | ||
|
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | ||
|
BioSig Technologies
BSGM
|
20.3 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | ||
|
ClearPoint Neuro
CLPT
|
45.9 M | $ 11.1 | -0.72 % | $ 314 M | ||
|
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
6.25 M | $ 0.61 | -2.42 % | $ 38 M | ||
|
Delcath Systems
DCTH
|
43.5 M | $ 11.53 | 4.63 % | $ 413 M | ||
|
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
101 M | - | - | $ 10.2 M | ||
|
Electromed
ELMD
|
15.3 M | $ 25.81 | 0.98 % | $ 218 M | ||
|
Butterfly Network
BFLY
|
88.8 M | $ 4.82 | -0.52 % | $ 1.02 B | ||
|
Second Sight Medical Products
EYES
|
16.2 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
526 M | $ 90.03 | -0.63 % | $ 12.2 B | ||
|
Helius Medical Technologies
HSDT
|
5.18 M | $ 2.16 | - | $ 1.31 M | ||
|
CONMED Corporation
CNMD
|
40.8 M | $ 36.64 | 2.12 % | $ 1.14 B | ||
|
Inspire Medical Systems
INSP
|
105 M | $ 48.25 | -12.02 % | $ 1.42 B | ||
|
IRIDEX Corporation
IRIX
|
6.03 M | $ 1.05 | -3.23 % | $ 17.8 M | ||
|
Integer Holdings Corporation
ITGR
|
17.2 M | $ 85.85 | 2.26 % | $ 2.98 B | ||
|
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
2.94 B | $ 82.91 | -0.5 % | $ 48.5 B | ||
|
OrthoPediatrics Corp.
KIDS
|
19.6 M | $ 17.04 | 7.98 % | $ 400 M | ||
|
LivaNova PLC
LIVN
|
636 M | $ 57.59 | -2.51 % | $ 3.14 B | ||
|
LENSAR
LNSR
|
13 M | $ 5.48 | -1.44 % | $ 65.5 M | ||
|
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.27 | -4.51 % | $ 51.7 M | ||
|
MiMedx Group
MDXG
|
166 M | $ 3.64 | 0.83 % | $ 538 M | ||
|
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | ||
|
Myomo
MYO
|
14.1 M | $ 0.88 | 1.69 % | $ 36.8 M | ||
|
NanoVibronix
NAOV
|
4.22 M | - | - | $ 1.08 M | ||
|
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | ||
|
Natus Medical Incorporated
NTUS
|
75.6 M | - | 1.94 % | $ 1.05 B | ||
|
Vivos Therapeutics
VVOS
|
2.03 M | $ 0.71 | -4.7 % | $ 7.29 M |